NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.55
-0.12 (-2.12%)
At close: Sep 17, 2025, 4:00 PM EDT
5.79
+0.24 (4.32%)
After-hours: Sep 17, 2025, 7:50 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $14.85 million as of September 17, 2025. Its market cap has decreased by -63.88% in one year.
Market Cap
14.85M
Enterprise Value
-14.87M
1-Year Change
-63.88%
Ranking
Category
Stock Price
$5.55
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $14.85M, a decrease of -96.60%. That is a compound annual growth rate of -41.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 14.85M | -31.22% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.79B |
| Johnson & Johnson | 425.94B |
| AbbVie | 382.37B |
| UnitedHealth Group | 308.30B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.49B |